BioPharma Credit (BPCR) Stock Chart & Stock Price History GBX 0.88 +0.00 (+0.11%) As of 03/27/2025 12:46 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsDividendInsider TradesBuy This Stock BioPharma Credit Stock Price Performance 5 Day Performance-0.79%1 Month Performance+1.97%3 Month Performance+4.14%6 Month Performance-2.54%Year-To-Date Performance-0.34%1 Year Performance-1.67% Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. Email Address BPCR Stock Chart for Friday, March, 28, 2025 BPCR Chart by TradingViewRemove Ads BioPharma Credit Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization03/26/2025GBX 0.88GBX 0.89+0.91%GBX 0.89GBX 0.87551,605 shs£1.05 billion03/25/2025GBX 0.88GBX 0.88-0.45%GBX 0.89GBX 0.871.67 million shs£1.04 billion03/24/2025GBX 0.89GBX 0.88-0.68%GBX 0.89GBX 0.88655,470 shs£1.05 billion03/21/2025GBX 0.88GBX 0.89+0.45%GBX 0.89GBX 0.88333,264 shs£1.05 billion03/20/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88742,598 shs£1.05 billion03/19/2025GBX 0.89GBX 0.88-0.45%GBX 0.89GBX 0.881.34 million shs£1.05 billion03/18/2025GBX 0.89GBX 0.89-0.22%GBX 0.89GBX 0.88540,835 shs£1.05 billion03/17/2025GBX 0.89GBX 0.89+0.23%GBX 0.89GBX 0.88343,118 shs£1.06 billion03/14/2025GBX 0.88GBX 0.89+0.45%GBX 0.89GBX 0.89479,674 shs£1.05 billion03/13/2025GBX 0.89GBX 0.88-0.90%GBX 0.92GBX 0.883.48 million shs£1.05 billion Get the Latest News and Ratings for BPCR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. 03/12/2025GBX 0.89GBX 0.89+0.22%GBX 0.90GBX 0.892.25 million shs£1.06 billion03/11/2025GBX 0.89GBX 0.89+0.45%GBX 0.90GBX 0.8914.17 million shs£1.06 billion03/10/2025GBX 0.88GBX 0.89+0.91%GBX 0.90GBX 0.881.74 million shs£1.05 billion03/07/2025GBX 0.88GBX 0.88GBX 0.89GBX 0.88899,759 shs£1.04 billion03/06/2025GBX 0.87GBX 0.88+1.15%GBX 0.88GBX 0.87492,919 shs£1.04 billion03/05/2025GBX 0.87GBX 0.87-0.46%GBX 0.88GBX 0.871.48 million shs£1.03 billion03/04/2025GBX 0.87GBX 0.87-0.23%GBX 0.88GBX 0.871.61 million shs£1.04 billion03/03/2025GBX 0.87GBX 0.87+0.69%GBX 0.88GBX 0.871.25 million shs£1.04 billion02/28/2025GBX 0.86GBX 0.87+0.46%GBX 0.87GBX 0.861.21 million shs£1.03 billion02/27/2025GBX 0.86GBX 0.86GBX 0.87GBX 0.862.23 million shs£1.03 billion02/26/2025GBX 0.86GBX 0.86GBX 0.88GBX 0.861.51 million shs£1.03 billion Related Companies Polar Capital Technology Trust Stock Price Chart Alliance Trust Stock Price Chart Petershill Partners Stock Price Chart abrdn Stock Price Chart Man Group Stock Price Chart Burford Capital Stock Price Chart 3i Infrastructure Stock Price Chart JPMorgan Global Growth & Income Stock Price Chart Bridgepoint Group Stock Price Chart RIT Capital Partners Stock Price Chart Receive BPCR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for BioPharma Credit and its competitors with MarketBeat's FREE daily newsletter. This page (LON:BPCR) was last updated on 3/28/2025 by MarketBeat.com Staff From Our PartnersA $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOWExpert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...Stansberry Research | SponsoredElon Warns: Exec Order 14024 Targets DollarExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredEx CIA predicts 40% “double crash” – April 11The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...Paradigm Press | SponsoredElon Musk is helping print “new gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredMost gold “analysts” aren’t really gold analysts… [watch out]People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredJust Revealed: The chip company making AI look primitiveIn his just-released video presentation, this renowned market strategist — who's been called "one of the most ...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioPharma Credit Please log in to your account or sign up in order to add this asset to your watchlist. Share BioPharma Credit With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BPCR Stock Free BPCR Stock Alerts